IDT Corporation Class B (IDT)

On our desk, we are closely tracking the valuation multiple after the latest earnings beat. IDT is trading at a P/E of roughly 20.64 with a market cap around $1.65 billion, while outperforming the SandP 500 over the past month. The margin expansion—specifically the 170 basis point increase in gross profit margin to 38.8%—provides a solid fundamental floor, but we need to see if the multiple can expand further given the historical trading ranges between $44.77 and $71.12.

From a hedge fund PM perspective, the smart-money sentiment remains mixed. While 179 tracked 13F filers show a combined $629.5M in reported value, recent insider activity shows a net negative trend over the past 180 days with multiple insider sells and zero open-market buys. Specifically, the open-market sale of 20,000 shares by EVP Menachem Ash and subsequent Form 144 filings by other officers warrant cautious interpretation of internal sentiment.

As a risk manager reviewing the capital structure, I note that IDT ended April 30, 2026, with $251.4 million in cash, cash equivalents, and current securities with zero outstanding debt. However, the drop in quarterly operating cash flow to $18.5 million due to working capital changes is a friction point that requires closer monitoring, especially as management raises its FY 2026 Adjusted EBITDA guidance to $150-$152 million.

As a bio-analyst turned telecom-adjacent specialist, I am impressed by the operating leverage demonstrated in IDT's growth engines. The 33% increase at NRS, 29% at Fintech, and 76% at net2phone highlight that these high-margin segments are successfully scaling and directly contributing to the record $122.5 million gross profit reported in Q3 2026.

On the options desk, implied volatility is reacting to the confluence of strong quarterly top-and-bottom-line beats—such as GAAP EPS ticking up to $0.87 and Adjusted EBITDA growing 13% to $37.5 million—offset by insider disposition. Traders should evaluate downside put spreads to protect gains after the stock's recent 7.5% monthly advance against a down broader market.